» Articles » PMID: 19117750

Evaluation of Data Quality in the Cancer Registry: Principles and Methods. Part I: Comparability, Validity and Timeliness

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2009 Jan 2
PMID 19117750
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

The value of the modern cancer registry and its ability to carry out cancer control activities rely heavily on the underlying quality of its data and the quality control procedures in place. This two-part review provides an update of the practical aspects and techniques for addressing data quality at the cancer registry. This first installment of the review examines the factors influencing three of the four key aspects, namely, the comparability, validity and timeliness of cancer registry data. Comparability of cancer data may be established through a comprehensive review of the registration routines in place. Validity is examined via numerical indices of that permit comparisons with other registries, or, within a registry, over time, or with respect to specified subsets of cases. There are no international guidelines for timeliness at present, although specific standards for the abstraction and reporting of registry have been set out by certain organisations.

Citing Articles

Digital integration between hospitals and local health authorities for enhanced vaccination coverage among frail patients: the CareVax study protocol.

Lontano A, Regazzi L, Tona D, Di Pumpo M, Porcelli M, Cacciuttolo M Front Public Health. 2025; 13:1490244.

PMID: 39949559 PMC: 11822475. DOI: 10.3389/fpubh.2025.1490244.


The incidence, mortality, and survival rate of colorectal cancer in Xiamen, China, from 2011 to 2020.

Qiu L, Luo W, Chen Y, Guo Z, Quan J, Chi J BMC Public Health. 2025; 25(1):176.

PMID: 39819599 PMC: 11736963. DOI: 10.1186/s12889-024-21010-w.


Lung cancer incidence and mortality in trend and prediction between 2012-2030 in Shandong Province, using a Bayesian age-period-cohort model.

Jiang F, Fu Z, Chu J, Ren J, Xu C, Xu X Front Oncol. 2024; 14:1451589.

PMID: 39697222 PMC: 11652362. DOI: 10.3389/fonc.2024.1451589.


Bayesian age-period-cohort projection of cancers in Iran: a modeling study.

Barati H, Pourhoseingholi M, Roshandel G, Hashemi Nazari S BMC Cancer. 2024; 24(1):1538.

PMID: 39696020 PMC: 11657364. DOI: 10.1186/s12885-024-13289-0.


Temporal trends of incidence, mortality, and survival of liver cancer during 2011-2020 in Fujian Province, Southeast China.

Xiang Z, Huang Y, Ma J, Lin Y, Wen Y, Zhou Y Arch Public Health. 2024; 82(1):233.

PMID: 39633411 PMC: 11616380. DOI: 10.1186/s13690-024-01462-7.